|
1
|
Warburg O: Ueber den Stoffwechsel der
Tumoren. Constable; London: 1930
|
|
2
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hsu PP and Sabatini DM: Cancer cell
metabolism: Warburg and beyond. Cell. 134:703–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Michelakis ED, Webster L and Mackey LR:
Dichloroacetate (DCA) as a potential metabolic-targeting therapy
for cancer. Br J Cancer. 99:989–994. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Plas DR and Thompson CB: Cell metabolism
in the regulation of programmed cell death. Trends Endocrinol
Metab. 13:75–78. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bonnet S, Archer SL, Allalunis-Turner J,
Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta
L, Bonnet S, et al: A mitochondria-K+ channel axis is suppressed in
cancer and its normalization promotes apoptosis and inhibits cancer
growth. Cancer Cell. 11:37–51. 2007.
|
|
7
|
Stacpoole PW: The pharmacology of
dichloroacetate. Metabolism. 38:1124–1144. 2006. View Article : Google Scholar
|
|
8
|
Stacpoole PW, Gilbert LR, Neiberger RE,
Carney PR, Valenstein E, Theriaque DW and Shuster JJ: Evaluation of
long-term treatment of children with congenital lactic acidosis
with dichloroacetate. Pediatrics. 121:1223–1228. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luciani F, Spada M, Milito AD, Molinari A,
Rivoltini L, Montinaro A, Marra M, Lugini L, Logozzi M, Lozupone F,
et al: Effect of proton pump inhibitor pretreatment on resistance
of solid tumors to cytotoxic drugs. J Natl Cancer Inst.
96:1702–1713. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Milito AD, Iessi E, Logozzi M, Lozupone F,
Spada M, Marino ML, Federici C, Perdicchio M, Matarrese P, Lugini
L, et al: Proton pump inhibitors induce apoptosis of human B-cell
tumors through a caspase-independent mechanism involving reactive
oxygen species. Cancer Res. 67:5408–5417. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
De Milito A, Canese R, Marino ML, Borghi
M, Iero M, Villa A, Venturi G, Lozupone F, Iessi E, Logozzi M, et
al: pH-dependent antitumor activity of proton pump inhibitors
against human melanoma is mediated by inhibition of tumor acidity.
Int J Cancer. 27:207–219. 2010.PubMed/NCBI
|
|
12
|
Michelakis ED, Sutendra G, Dromparis P,
Webster L, Haromy A, Niven E, Maguire C, Gammer TL, Mackey JR,
Fulton D, et al: Metabolic modulation of glioblastoma with
dichloroacetate. Sci Trasl Med. 2:31–34. 2010.PubMed/NCBI
|
|
13
|
Shi S and Klotz U: Proton pump inhibitors:
an update of their clinical use and pharmacokinetics. Eur J Clin
Pharmacol. 64:935–951. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Katagiri F, Inoue S, Itoh H and Takayema
M: Omeprazole raises somatostatin and motilin in human plasma. Biol
Pharm Bull. 28:370–372. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Frucht H, Maton PN and Jensen RT: Use of
omeprazole in patients with Zollinger-Ellison syndrome. Dig Dis
Sci. 36:394–404. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thomson ABR, Sauve MD, Kassam N and
Kamitakahara H: Safety of the long-term use of proton pump
inhibitors. World J Gastroenterol. 16:2323–2330. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Udelnow A, Kreyes A, Ellinger S,
Landfester K, Walther P, Klapperstueck T, Wohlrab J, Henne-Bruns D,
Knippschild U and Würl P: Omeprazole inhibits proliferation and
modulates autophagy in pancreatic cancer cells. PLoS One.
6:e201432011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shroads AL, Guo X, Dixit V, Liu HP, James
MO and Stacpoole PW: Age-dependent kinetics and metabolism of
dichloroacetate: possible relevance to toxicity. J Pharmacol Exp
Ther. 324:1163–1171. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stacpoole PW, Henderson GN, Yan Z, Cornett
R and James MO: Pharmacokinetics, metabolism and toxicology of
dichloroacetate. Drug Metab Rev. 30:499–539. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Subramanian K and Ramaian AS: Development
of a less toxic dichloroacetate analogue by docking and descriptor
analysis. Bioinformation. 5:73–76. 2010. View Article : Google Scholar : PubMed/NCBI
|
